Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough
Authors:
- 1 January 2002
- journal article
- case report
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 9 (1) , 71-74
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis CHepatology, 2000
- A Relationship between the Evolution of Hepatitis C Virus Variants, Liver Damage, and Hepatocellular Carcinoma in Patients with Hepatitis C ViremiaThe Journal of Infectious Diseases, 2000
- Liver biopsy in hepatitis CJournal of Hepatology, 1999
- Hepatitis C Virus Rna Profiles in Chronically Infected Individuals: Do They Relate to Disease Activity?Hepatology, 1999
- Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activityHepatology, 1998
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Hepatitis C Virus Type 1b (II) Infection in France and ItalyAnnals of Internal Medicine, 1995
- Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levelsHepatology, 1994
- Persistent hepatitis C viraemia without liver diseaseThe Lancet, 1993
- Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCVThe Lancet, 1992